JPMorgan Chase to restrict purchases of cannabis-related stocks, report says

Did you miss the webinar “Women Leaders in Cannabis: Shattering the Grass Ceiling?” Head to MJBiz YouTube to watch it now!


Banking giant JPMorgan Chase & Co. informed its brokerage clients they’ll no longer be allowed to purchase cannabis-related stocks and securities starting Nov. 8.

Reuters on Tuesday cited an internal JPMorgan letter to brokers that said, in part, “J.P. Morgan (JPMS) has introduced a framework that is designed to comply with U.S. money laundering laws and regulations by restricting certain activities in the securities of U.S. Marijuana Related Businesses.”

The New York-based bank’s restriction applies to any company that has a “direct nexus to marijuana-related activities,” even those that aren’t traded on major exchanges such as the Nasdaq, New York Stock Exchange or Toronto Stock Exchange.

After Nov. 8, JPMorgan clients with positions in marijuana companies will be allowed to liquidate their shares, according to the bank’s letter.

The pivot by JPMorgan follows a similar move earlier this year by global investment firm Credit Suisse Group, which told clients it was calling off all transactions involving marijuana-related companies in the United States.

That decision by Credit Suisse Group reportedly led to a huge selloff of cannabis stocks.

The learning curve for entering the cannabis industry is steep. Start with the fundamentals.

MJBiz Cannabis 101 Email Course

A 10-part email course designed to educate new hires and aspiring professionals on the key fundamental areas of the legal cannabis industry, including:

  • History of legal cannabis in America
  • Overview of plant-touching + ancillary business sectors
  • Cannabis finance and investing
  • Cannabis marketing and brand building
  • Employment + hiring opportunities
  • And much more!

Gain a comprehensive understanding of this complex industry with this free resource.

U.S. Cannabis Council CEO Steve Hawkins called JPMorgan’s decision “beyond disappointing.”

“JPMorgan’s new policy is regressive and at odds with the majority of Americans, who want legal, regulated cannabis. What’s more, it’s self-defeating,” Hawkins said in a statement. “The end of federal cannabis prohibition is within site, and the industry is already growing rapidly.

“I imagine more than a few JPMorgan customers will take issue with being blocked from one of the hottest industries on the market today. JPMorgan is on the wrong side of history on this and will come to regret its decision.”